Skip to Content

Circulating Methylated-HOXA9 Tumor DNA as a Biomarker in Recurrent Breast Cancer

In this MEDtalk, MD Stine Bakkesen Bruun presents interesting findings on a potential new biomarker for prognosis and mortality in recurrent breast cancer. The biomarker is circulating methylated-HOXA9 tumor DNA, as this gene may act as a tumor suppressor in carcinomas and induce breast cancer progression.

Stine Bakkensen Bruun

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top